Following the money: Burisma privately urged Hunter Biden to stop investigation By Rowan Scarborough - The Washington Times Shares
Comer alarmed by White House ‘secrecy’ after more classified docs found at Biden home By Joseph Clark - The Washington Times Shares
GOP Rep. James Comer lays out House Oversight panel priorities By Ramsey Touchberry - The Washington Times Shares
Republicans press Justice Department on political cyberattacks on pro-life websites By Kerry Picket - The Washington Times Shares
House investigators want gun companies to testify on marketing in wake of mass shootings By Tom Howell Jr. - The Washington Times Shares
House GOP prepping investigations of Hunter Biden, Afghan pullout, COVID-19 origins By Kerry Picket - The Washington Times Shares
Trump says House Dems ‘dishonestly’ portrayed call to acting attorney general on election results By Dave Boyer - The Washington Times Shares
House subpoenas embattled Postal Service leader over delays By ANTHONY IZAGUIRRE - Associated Press Shares
William Barr, Wilbur Ross contempt of Congress proceedings approved by House Oversight Committee By Stephen Dinan - The Washington Times Shares
House panel votes to hold top US officials in contempt By MATTHEW DALY and MICHAEL BALSAMO - Associated Press Shares
Michael Cohen not in trouble for misleading committee, House chairman says By Stephen Dinan - The Washington Times Shares
Jim Jordan, Mark Meadows refer Michael Cohen to Justice Department for perjury By Jeff Mordock - The Washington Times Shares
Cohen says Trump inflated his wealth in bid to buy Bills By JIM MUSTIAN and BERNARD CONDON and JOHN WAWROW - Associated Press Shares
EPA security chief, Superfund head leave amid ethics probes By ELLEN KNICKMEYER - Associated Press Shares
Chaffetz to resign, raising doubts about Trump probe By MICHELLE L. PRICE and BRADY McCOMBS - Associated Press Shares
Michael Flynn warned about foreign payments in 2014, congressional probe says By Dan Boylan and Dave Boyer - The Washington Times Shares
House panel: Mylan CEO minimized EpiPen profits in testimony By MATTHEW DALY - Associated Press Shares